/FORA

FORA Stock - Forian Inc.

Q: What is the analyst price target for FORA?

Analyst price target information is not currently available for FORA.

Q: What is FORA's market cap?

Market capitalization information is not currently available for FORA.

Healthcare|Medical - Healthcare Information Services|NASDAQ

$2.12+1.92%

+$0.04 (+1.92%) • Jan 12

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+112.3%upside

Target: $4.50

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for FORA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.03

52W High$4.03

52W Low$1.64

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$20.15M	$20.48M	$16.42M	$16.88M	$544,871
Gross Profit	$12.82M	$15.00M	$11.37M	$12.16M	$506,578
Gross Margin	63.6%	73.3%	69.2%	72.1%	93.0%
Operating Income	$-6,986,961	$-5,595,012	$-18,952,810	$-27,616,757	$-4,983,757
Net Income	$-3,771,070	$11.11M	$-25,971,971	$-26,551,105	$-4,980,183
Net Margin	-18.7%	54.2%	-158.2%	-157.3%	-914.0%
EPS	$-0.12	$0.36	$-0.81	$-0.84	$-0.17

Company Overview

Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

100%

Hold / Neutral

Sell / Underperform

Analyst Consensus🟢 Bullish

2 Bullish0 Neutral/Bearish

Price Targets

Average Target

↑ 230.2% Upside

Now

Low

Average

High

Based on 2 analysts

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
December 20th 2023	ROTH MKM	Initiation	Buy	$5
April 8th 2022	Lake Street	Initiation	Buy	$9

Earnings History & Surprises

FORA

Beat Rate

71%

Last 14 quarters

Avg Surprise

+23.4%

EPS vs Estimate

Beats / Misses

10/4

Last 12 quarters

Latest EPS

$0.02

Q4 2025

EPS Surprise History

Q1 24

+233.3%

$0.04vs$0.01

Q2 24

No data

Q3 24

-300.0%

$-0.03vs$-0.01

Q4 24

+66.7%

$0.03vs$0.02

Q1 25

-150.0%

$-0.01vs$0.02

Q2 25

-300.0%

$-0.04vs$0.02

Q3 25

+200.0%

$0.03vs$0.01

Q4 25

+100.0%

$0.02vs$0.01

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 12, 2026	—	—	—	—
Q1 2026	Feb 13, 2026	$0.01	—	—	—
Q4 2025	Nov 14, 2025	$0.01	$0.02	+100.0%	✓ BEAT
Q3 2025	Aug 13, 2025	$0.01	$0.03	+200.0%	✓ BEAT
Q2 2025	May 14, 2025	$0.02	$-0.04	-300.0%	✗ MISS
Q1 2025	Mar 27, 2025	$0.02	$-0.01	-150.0%	✗ MISS
Q4 2024	Nov 13, 2024	$0.02	$0.03	+66.7%	✓ BEAT
Q3 2024	Aug 14, 2024	$-0.01	$-0.03	-300.0%	✗ MISS
Q2 2024	May 14, 2024	—	$0.01	—	—
Q1 2024	Mar 28, 2024	$0.01	$0.04	+233.3%	✓ BEAT
Q4 2023	Nov 9, 2023	$0.00	$0.03	+532.9%	✓ BEAT
Q3 2023	Aug 10, 2023	$-0.05	$-0.03	+40.0%	✓ BEAT
Q2 2023	May 12, 2023	$-0.11	$-0.08	+27.3%	✓ BEAT
Q1 2023	Mar 27, 2023	$0.15	$-0.11	-173.3%	✗ MISS
Q4 2022	Nov 14, 2022	$-0.17	$-0.16	+5.9%	✓ BEAT
Q3 2022	Aug 11, 2022	$-0.23	$-0.17	+26.1%	✓ BEAT
Q2 2022	May 12, 2022	$-0.26	$-0.21	+19.2%	✓ BEAT
Q1 2022	Mar 24, 2022	—	$-0.25	—	—
Q4 2021	Nov 11, 2021	—	$-0.22	—	—
Q3 2021	Aug 12, 2021	—	$-0.23	—	—

Frequently Asked Questions about FORA

What is FORA's current stock price?

Forian Inc. (FORA) is currently trading at $2.12 per share. The stock has moved +1.92% today.

What is the analyst price target for FORA?

The average analyst price target for FORA is $4.50, based on 1 analyst.

What sector is Forian Inc. in?

Forian Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.

What is FORA's market cap?

Forian Inc. has a market capitalization of $0.07 billion, making it a small-cap company.

Does FORA pay dividends?

No, Forian Inc. does not currently pay a dividend to shareholders.